These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23414308)

  • 1. Gene expression of tumor necrosis factor receptor associated-factor (TRAF)-1 and TRAF-2 in inflammatory bowel disease.
    Qiao YQ; Shen J; Gu Y; Tong JL; Xu XT; Huang ML; Ran ZH
    J Dig Dis; 2013 May; 14(5):244-50. PubMed ID: 23414308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of real-time polymerase chain reaction for quantifying TNF-alpha mRNA expression in inflamed colorectal mucosa: an approach to optimize procedures for clinical use.
    Cui G; Olsen T; Christiansen I; Vonen B; Florholmen J; Goll R
    Scand J Clin Lab Invest; 2006; 66(3):249-59. PubMed ID: 16714253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the pathogenesis of inflammatory bowel disease: transcription factors analysis in bioptic tissues from pediatric patients.
    Pierdomenico M; Stronati L; Costanzo M; Vitali R; Di Nardo G; Nuti F; Oliva S; Cucchiara S; Negroni A
    J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):271-9. PubMed ID: 21336161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease.
    Steenholdt C; Andresen L; Pedersen G; Hansen A; Brynskov J
    Scand J Gastroenterol; 2009; 44(2):195-204. PubMed ID: 18985539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
    Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
    J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].
    Zhang Z; Zhao X; Lv C; Li C; Zhi F
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1548-52. PubMed ID: 23174572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the fragile histidine triad (FHIT) gene in inflammatory bowel disease.
    Wierzbicki PM; Adrych K; Kartanowicz D; Wypych J; Stanislawowski M; Zwolinska-Wcislo M; Celinski K; Skrodzka D; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():57-62. PubMed ID: 20083852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays.
    Costello CM; Mah N; Häsler R; Rosenstiel P; Waetzig GH; Hahn A; Lu T; Gurbuz Y; Nikolaus S; Albrecht M; Hampe J; Lucius R; Klöppel G; Eickhoff H; Lehrach H; Lengauer T; Schreiber S
    PLoS Med; 2005 Aug; 2(8):e199. PubMed ID: 16107186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of tumor necrosis factor-alpha signaling adapter proteins in peripheral blood mononuclear cells from patients with systemic lupus erythematosus].
    Zhu LJ; Yang X; Chen WY; Li XY; Ji YL; Mao HP; Nie J; Yu XQ
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3102-6. PubMed ID: 18269865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease.
    Vitali R; Stronati L; Negroni A; Di Nardo G; Pierdomenico M; del Giudice E; Rossi P; Cucchiara S
    Am J Gastroenterol; 2011 Nov; 106(11):2029-40. PubMed ID: 21788990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
    Akazawa A; Sakaida I; Higaki S; Kubo Y; Uchida K; Okita K
    J Gastroenterol; 2002; 37(5):345-53. PubMed ID: 12051533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
    Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
    Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
    Siddique I; Hasan F; Khan I
    Scand J Gastroenterol; 2009; 44(1):56-64. PubMed ID: 18785066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G Protein-Coupled Receptor 30 (GPR30) Expression Pattern in Inflammatory Bowel Disease Patients Suggests its Key Role in the Inflammatory Process. A Preliminary Study.
    Włodarczyk M; Sobolewska-Włodarczyk A; Cygankiewicz AI; Jacenik D; Piechota-Polańczyk A; Stec-Michalska K; Krajewska WM; Fichna J; Wiśniewska-Jarosińska M
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):29-35. PubMed ID: 28338111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
    Klebl FH; Olsen JE; Jain S; Doe WF
    J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.
    Zirlik A; Bavendiek U; Libby P; MacFarlane L; Gerdes N; Jagielska J; Ernst S; Aikawa M; Nakano H; Tsitsikov E; Schönbeck U
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1101-7. PubMed ID: 17332487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.
    Renner M; Bergmann G; Krebs I; End C; Lyer S; Hilberg F; Helmke B; Gassler N; Autschbach F; Bikker F; Strobel-Freidekind O; Gronert-Sum S; Benner A; Blaich S; Wittig R; Hudler M; Ligtenberg AJ; Madsen J; Holmskov U; Annese V; Latiano A; Schirmacher P; Amerongen AV; D'Amato M; Kioschis P; Hafner M; Poustka A; Mollenhauer J
    Gastroenterology; 2007 Nov; 133(5):1499-509. PubMed ID: 17983803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
    Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.